TP53 and undifferentiated carcinoma: Type II tumours (including high-grade serous carcinoma, high-grade endometrioid carcinoma, undifferentiated carcinoma and carcinosarcoma) have a very aggressive biological behaviour, are usually in advanced stage at presentation, often harbour p53 gene mutations, and are genetically unstable.